ArticleCommunications medicine2022
Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma.
Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it